Skip to search formSkip to main contentSkip to account menu

panepoxydone

Known as: 5-hydroxy-3-(1-hydroxy-3-methyl-2-butenyl)-7-oxabicylo(4.1.0)hept-3-en-2-one 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Bridged Bicyclo Compounds, Heterocyclic

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Abstract 5571: Antitumor activity of a novel natural therapeutic agent against triple negative breast cancer.
Purpose: Triple-negative breast cancer (TNBC), representing up to 20% of all breast cancer cases, is a highly diverse group of… 
2013
2013
Abstract P1-07-07: Targeting reversal of epithelial-mesenchymal transition through FOXM1 inhibition in breast cancer cells
Purpose: Triple-negative breast cancer (TNBC), representing up to 20% of all breast cancer cases, is a highly diverse group of… 
2012
2012
Tumor necrosis factor (TNF)-α upregulates progesterone receptor-A by activating the NF-κB signaling pathway in human decidua after labor onset.
2010
2010
In vitro activity of hypnophilin from Lentinus strigosus: a potential prototype for Chagas disease and leishmaniasis chemotherapy.
Hypnophilin and panepoxydone, terpenoids isolated from Lentinus strigosus, have significant inhibitory activity on Trypanosoma… 
Review
2006
Review
2006
Blocking NF-kappaB as a potential strategy to treat adult T-cell leukemia/lymphoma.
Adult T-cell leukemia/lymphoma (ATL), a fatal T-cell leukemia/lymphoma resistant to chemotherapy, is caused by human T-cell… 
2004
2004
Combination of NF-κB inhibitors with anticancer drugs: Synergism or antagonism?
1999 Activation of NF-κB is often observed following treatment with topoisomerase poisons and is generally considered to relay an… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)